These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26390866)

  • 1. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
    ; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
    Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.
    Flegg JA; Guérin PJ; Nosten F; Ashley EA; Phyo AP; Dondorp AM; Fairhurst RM; Socheat D; Borrmann S; Björkman A; Mårtensson A; Mayxay M; Newton PN; Bethell D; Se Y; Noedl H; Diakite M; Djimde AA; Hien TT; White NJ; Stepniewska K
    Malar J; 2013 Nov; 12():411. PubMed ID: 24225303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
    Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM
    Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
    Flegg JA; Guerin PJ; White NJ; Stepniewska K
    Malar J; 2011 Nov; 10():339. PubMed ID: 22074219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of artemisinin resistance in Plasmodium falciparum malaria.
    Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
    N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
    Hien TT; Thuy-Nhien NT; Phu NH; Boni MF; Thanh NV; Nha-Ca NT; Thai le H; Thai CQ; Toi PV; Thuan PD; Long le T; Dong le T; Merson L; Dolecek C; Stepniewska K; Ringwald P; White NJ; Farrar J; Wolbers M
    Malar J; 2012 Oct; 11():355. PubMed ID: 23101492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.
    Tun KM; Jeeyapant A; Imwong M; Thein M; Aung SS; Hlaing TM; Yuentrakul P; Promnarate C; Dhorda M; Woodrow CJ; Dondorp AM; Ashley EA; Smithuis FM; White NJ; Day NP
    Malar J; 2016 Mar; 15():185. PubMed ID: 27036739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.
    Huang F; Tang L; Yang H; Zhou S; Sun X; Liu H
    Malar J; 2012 Aug; 11():278. PubMed ID: 22898135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia.
    Noedl H; Se Y; Sriwichai S; Schaecher K; Teja-Isavadharm P; Smith B; Rutvisuttinunt W; Bethell D; Surasri S; Fukuda MM; Socheat D; Chan Thap L
    Clin Infect Dis; 2010 Dec; 51(11):e82-9. PubMed ID: 21028985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
    Lopera-Mesa TM; Doumbia S; Chiang S; Zeituni AE; Konate DS; Doumbouya M; Keita AS; Stepniewska K; Traore K; Diakite SA; Ndiaye D; Sa JM; Anderson JM; Fay MP; Long CA; Diakite M; Fairhurst RM
    J Infect Dis; 2013 Jun; 207(11):1655-63. PubMed ID: 23448727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.
    WWARN K13 Genotype-Phenotype Study Group
    BMC Med; 2019 Jan; 17(1):1. PubMed ID: 30651111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
    Phyo AP; Nkhoma S; Stepniewska K; Ashley EA; Nair S; McGready R; ler Moo C; Al-Saai S; Dondorp AM; Lwin KM; Singhasivanon P; Day NP; White NJ; Anderson TJ; Nosten F
    Lancet; 2012 May; 379(9830):1960-6. PubMed ID: 22484134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin resistance in Plasmodium falciparum malaria.
    Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ
    N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.